TERAPIE ALTERNATIVE DELLA NEUROTOXOPLASMOSI IN AIDS: CONTRIMOSSAZOLO E CLINDAMICINA

Translated title of the contribution: Therapeutic alternatives of toxoplasma encephalitis in AIDS patients: Cotrimoxazole and clindamycin

V. Del Bono, A. Canessa, P. De Leo, N. Piersantelli, A. Terragna

Research output: Contribution to journalArticlepeer-review

Abstract

Twenty-four AIDS patients with Toxoplasma encephalitis receiving cotrimoxazole and 5 receiving pyrimethamine plus clindamycin have been examined. Clinical and radiological response to treatment was evaluated and product limit method for survival data analysis was used. Eighteen out of 24 patients receiving cotrimoxazole and 3 out of 5 patients receiving clindamycin showed both clinical and radiological response. Cotrimoxazole was proven to be effective in treatment of Toxoplasma encephalitis and may represent an alternative to the choice therapy sulfadiazine-pyrimetamine. The actual efficacy of clindamycin has still to be evaluated.

Translated title of the contributionTherapeutic alternatives of toxoplasma encephalitis in AIDS patients: Cotrimoxazole and clindamycin
Original languageItalian
Pages (from-to)989-991
Number of pages3
JournalGiornale di Malattie Infettive e Parassitarie
Volume43
Issue number11
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Parasitology

Fingerprint Dive into the research topics of 'Therapeutic alternatives of toxoplasma encephalitis in AIDS patients: Cotrimoxazole and clindamycin'. Together they form a unique fingerprint.

Cite this